Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

SPRB
Spruce Biosciences, Inc. Common Stock
stock NASDAQ

At Close
Dec 26, 2025 3:59:30 PM EST
84.60USD+0.714%(+0.60)36,870
0.00Bid   0.00Ask   0.00Spread
Pre-market
Dec 23, 2025 8:18:30 AM EST
86.00USD+2.381%(+2.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
08:04AM EST  Spruce Biosciences Provides Clinical Program Updates And Outlook For 2022   Benzinga
Jan 5, 2022
08:20AM EST  Spruce Biosciences Names Javier Szwarcberg CEO   RTTNews
08:00AM EST  Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer   Business Wire
Dec 21, 2021
08:12AM EST  The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail   Benzinga
Dec 20, 2021
02:49PM EST  Mid-Afternoon Market Update: Dow Tumbles 500 Points; Bluerock Residential Growth Shares Spike Higher   Benzinga
12:35PM EST  Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump   Benzinga
10:09AM EST  Mid-Morning Market Update: Markets Open Lower; Carnival Reports Downbeat Q4 Revenue   Benzinga
07:25AM EST  The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.10 A.M. ET).   RTTNews
Dec 17, 2021
10:18AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021   Benzinga
05:52AM EST  Oppenheimer Initiates Coverage On Spruce Biosciences with Outperform Rating, Announces Price Target of $15   Benzinga
Dec 16, 2021
04:08PM EST  Watching Spruce Biosciences; Hearing Oppenheimer Initiates Outperform, $15 Price Target   Benzinga
Dec 10, 2021
01:42PM EST  Spruce Biosciences Wins Patent Trial Related To Tildacerfont Patent As Post Grant Review Filed By Neurocrine Biosciences Was Not Instituted   Benzinga
12:41PM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021   Benzinga
08:37AM EST  Benchmark Initiates Coverage On Spruce Biosciences with Speculative Buy Rating, Announces Price Target of $7   Benzinga
Nov 23, 2021
10:17AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021   Benzinga
06:23AM EST  Cowen & Co. Downgrades Spruce Biosciences to Market Perform   Benzinga
Nov 22, 2021
10:31AM EST  Spruce Biosciences Sponsored Study Titled 'A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH' Posted To ClinicalTrials.gov; Study Not Yet Recruiting   Benzinga
Nov 16, 2021
10:11AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021   Benzinga
09:59AM EST  HC Wainwright & Co. Maintains Buy on Spruce Biosciences, Lowers Price Target to $20   Benzinga
08:56AM EST  Credit Suisse Maintains Outperform on Spruce Biosciences, Lowers Price Target to $6   Benzinga
07:14AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
05:35AM EST  SVB Leerink Downgrades Spruce Biosciences to Market Perform, Lowers Price Target to $5   Benzinga
Nov 15, 2021
06:15PM EST  Spruce Biosciences Q3 EPS $(0.49) Up From $(12.35) YoY   Benzinga
04:38PM EST  Spruce Biosciences Names Mike Grey As Interim CEO   Benzinga
04:01PM EST  Spruce Biosciences Appoints Mike Grey as Interim CEO   Business Wire
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
Sep 29, 2021
08:13AM EDT  The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug   Benzinga
Sep 23, 2021
07:57AM EDT  The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data   Benzinga
Sep 22, 2021
07:45AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs   Benzinga
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 17, 2021
07:36AM EDT  The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold   Benzinga
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 11, 2021
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Aug 10, 2021
05:01PM EDT  Spruce Biosciences Q2 EPS $(0.50) Up From $(8.43) YoY   Benzinga
04:06PM EDT  Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates   Business Wire
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
07:55AM EDT  The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 19, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2021   Benzinga
06:45AM EDT  HC Wainwright & Co. Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $30   Benzinga
Jul 7, 2021
11:38AM EDT  Tildacerfont: New Drug Provides Hope, Treatments After 50-Year-Long Drought   Benzinga
Jul 1, 2021
10:01AM EDT  Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors   Benzinga
Jun 22, 2021
08:12AM EDT  The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal   Benzinga
Jun 21, 2021
08:06AM EDT  Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism   Benzinga
Jun 18, 2021
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 17, 2021
08:33AM EDT  The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme   Benzinga
Jun 16, 2021
08:20AM EDT  The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO   Benzinga
Jun 4, 2021
09:39AM EDT  The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact   Benzinga
May 27, 2021
08:24AM EDT  The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs   Benzinga
May 26, 2021
07:33AM EDT  The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing   Benzinga
May 24, 2021
08:12AM EDT  Spruce Biosciences Highlights Presentation Of Phase 2 Data For Tildacerfont In Adults With Congenital Adrenal Hyperplasia At 23rd European Congress Of Endocrinology   Benzinga
May 12, 2021
04:21PM EDT  Spruce Biosciences Q1 EPS $(0.42) Up From $(6.76) YoY   Benzinga
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 23, 2021
08:07AM EDT  Credit Suisse Maintains Outperform on Spruce Biosciences, Lowers Price Target to $26   Benzinga
Mar 22, 2021
04:08PM EDT  Spruce Biosciences Q4 EPS $(0.39) Beats $(0.59) Estimate   Benzinga
Mar 17, 2021
08:42AM EDT  Spruce Biosciences Presents Phase 1, Phase 2 Data For Tildacerfont In Adults With Congenital Afrenal Hyperplasia From Endcroine Society's 2021 Annual Meeting   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Jan 6, 2021
08:04AM EST  Spruce Biosciences Provides Corporate Update And Outlines Milestones For 2021   Benzinga
Dec 18, 2020
04:19PM EST  Spruce Biosciences File 13D Shows HealthCap Gas A 8.8% Stake In Co.   Benzinga
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 18, 2020
04:09PM EST  Spruce Biosciences Reports Q3 Net Loss of $9.6M Compared To $2.6M YoY   Benzinga
Nov 17, 2020
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
Nov 3, 2020
09:33AM EST  Benzinga's Top Upgrades, Downgrades For November 3, 2020   Benzinga
07:26AM EST  RBC Capital Initiates Coverage On Spruce Biosciences with Outperform Rating, Announces Price Target of $28   Benzinga
07:26AM EST  Cowen & Co. Initiates Coverage On Spruce Biosciences with Outperform Rating, Announces Price Target of $44   Benzinga
06:43AM EST  SVB Leerink Initiates Coverage On Spruce Biosciences with Outperform Rating, Announces Price Target of $35   Benzinga
04:42AM EST  Credit Suisse Initiates Coverage On Spruce Biosciences with Outperform Rating, Announces Price Target of $28   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 30, 2020
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Oct 9, 2020
11:38AM EDT  Spruce Biosciences Shares Open For Trade At $18.14; IPO Priced At $15/Share   Benzinga
10:03AM EDT  FuboTV Uplisting, Kronos Bio Highlight This Week's IPOs   Benzinga
09:11AM EDT  IPOs Happening Today, Friday, October 9, 2020: LCYAU, STTK, SPRB, IH, KRON, IPOD.U, IPOE.U, IPOF.U   Benzinga
08:49AM EDT  Spruce Biosciences Shares Will Open For Quote At 9:50 a.m. EDT, Expected To Open For Trade After 10:00 a.m. EDT, IPO Priced At $15.00/Share   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC